Identification of brain metastasis genes and therapeutic evaluation of histone deacetylase inhibitors in a clinically relevant model of breast cancer brain metastasis
Breast cancer brain metastases remain largely incurable. Although several mouse models have been developed to investigate the genes and mechanisms regulating breast cancer brain metastasis, these models often lack clinical relevance since they require the use of immunocompromised mice and/or are poo...
Main Authors: | Soo-Hyun Kim, Richard P. Redvers, Lap Hing Chi, Xiawei Ling, Andrew J. Lucke, Robert C. Reid, David P. Fairlie, Ana Carolina Baptista Moreno Martin, Robin L. Anderson, Delphine Denoyer, Normand Pouliot |
---|---|
Format: | Article |
Language: | English |
Published: |
The Company of Biologists
2018-07-01
|
Series: | Disease Models & Mechanisms |
Subjects: | |
Online Access: | http://dmm.biologists.org/content/11/7/DMM034850 |
Similar Items
-
Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
by: Masumeh Sanaei, et al.
Published: (2019-01-01) -
Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
by: Monica Phimmachanh, et al.
Published: (2020-10-01) -
Advanced Progress of Histone Deacetylases in Rheumatic Diseases
by: Liu XM, et al.
Published: (2024-02-01) -
4-Hexylresorcinol Inhibits Class I Histone Deacetylases in Human Umbilical Cord Endothelial Cells
by: Jwa-Young Kim, et al.
Published: (2021-04-01) -
Role of histone deacetylase inhibitors in non-neoplastic diseases
by: Chunxiao Zhou, et al.
Published: (2024-07-01)